Wednesday, February 8th at 11am EST | 10am CST | 8am PST Industry shifts in container closure integrity (CCI) are driving the next generation of quality control solutions. Understanding the physics behind the technologies and their relation to your application will carve a path of successful CCI assurance.
Thursday, January 27th 2022 at 11AM EST | 4PM GMT | 8AM PST In this webinar, experts provide an overview of the needs of different patient populations, and examine the common challenges leading to non-compliance. The experts also discuss how an orally dissolving tablet (ODT) provides a solution to address patient challenges and enables potentially more successful treatments.
Thursday January 27, 2022 at 11am EST | 10am CST | 8am PST In this new video series, Drug Digest, the Pharmaceutical Technology editors dive into APIs, excipients, and formulation advances, with a focus on pairing the right APIs and excipients for optimizing formulations and efficacy. Join the editors as they speak with experts from Bristol-Myers Squibb, BASF, Thermo Fisher Scientific, Wavelength Pharmaceuticals, and more to determine the most significant factors impacting API and excipient selection as well as the best modalities/drug product forms.
On Demand Webcast Nanoparticles have unique properties that are manipulated to create novel solutions, such as innovative drug delivery systems seen in today’s Covid-19 mRNA vaccines. This webinar explores the analytical techniques used for nanoparticle characterization and its growing significance in drug delivery systems.
Tuesday, 1/18/22 at 11am EST | 8am PST | 5pm CET | 4pm GMT In this presentation we look at the products available to support projects where high resolution weight determination is essential. We will also explain what is important when designing a system that requires an integrated weighing solution and the various factors that can influence the performance and final results.
Monday December 20, 2021 at 11am EST | 10am CST | 8am PST Pharmaceutical manufacturers are under increasing pressure to fast-track technological innovation while remaining compliant. What are the correct steps to reaching operational intelligence with end-to-end data integrity?
Thursday December 9th, 2021 at 11am EST | 10am CST | 8am PST Meet the Modern Lab. Scitara’s Chief Technology Officer Geoff Gerhardt,PhD, and Head of Product Management Dave Levy, discuss how the Scientific Integration Platform, and its foundational technology, Digital Lab Exchange, overcome the pharma industry’s most long-standing obstacles. With end-to-end connectivity, automation, and ability to manage an increasing volume of complex data, Dave and Geoff offer insight into how Scitara is delivering an exciting foundation for digital transformation. Scitara is developing the mechanisms that will make it relatively straightforward to harness the full value of data, and that means finding, analyzing, extracting and, if necessary, transforming data into a format required by the platforms to which it is transferred. Complete connectivity and retention of context flow will mean labs can push and retrieve contextualized insight into, and out of, data lakes, which can then be better mined and interrogated.
Wednesday, December 8, 2021 at 10am EST | 7am PST | 4pm CET | 3pm GMT How can the pharma packaging supply chain collaborate to make a significant contribution to GHG emissions reduction goals? Join the webcast on December 8th to learn what a net zero emission concept for pharmaceutical manufacturing and supply chain would look like, and the steps necessary to achieve it.
Thursday, December 2, 2021 at 4:00pm GMT | 11:00 am EDT What to look for to bring an inhaled medicine from feasibility study to commercial product, from a particle engineering, formulation, drug delivery and analytical characterization perspective. General rules will be supported through case studies
**Tuesday, Nov. 30, 2021 at 2pm EST | 1pm CST | 11am PST*** Formulation options for peptides in early development versus strategies for final dosage for design, keeping all options open. Peptide formulation strategies for rapid entry to the clinic. *** On demand available after final airing until November 30, 2022.***
**Wednesday, November 17, 2021 at 11am EST, 10am CST, 8am PST*** TE&L examples are presented for which the critical toxicological endpoints are discussed and evaluated by means of various methods, in terms of deriving appropriate safety limits. *** On demand available after final airing until November 17, 2022.***
Wednesday October 27th, 2021 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST Antibody products have evolved to be the cornerstone of the biopharmaceutical market and are a driving force in the pharmaceutical landscape. A variety of tools and technologies have contributed to the success and unrivaled growth of antibody products, learn how current and novel technologies may impact antibody product growth in the coming decades.
Tuesday, October 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Are you planning to turn your analytical HPLC method into a purification method? Are you converting your analytical-scale purification method to semi-prep or production scale? Learn how to set appropriate purification goals for purity, yield and throughput and what type of equipment will best fit your application.
Thursday, October 21, 2021 at 4pm CEST |10am EDT| 7am PDT| 3pm BST Protect not only your valuable product but also public health by ensuring correct storage choices. Gain insight into the effects of deep cold storage and a holistic approach to ensure Container Closure Integrity of sterile pharmaceuticals.
Tuesday, October 19, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST Join this webcast on digital tools for guiding the formulation development of poorly soluble drugs to learn about recent features of BASF’s virtual formulation assistant. Explore how to identify the most suitable formulation approach for your active ingredient.
October 4, 2021 at 3pm BST | 10am EST | 4pm CEST Join global industry and regulatory experts as they discuss current hot topics in extractables and leachables (E&L) testing for pharmaceuticals, biopharmaceuticals and medical devices.
Thursday, September 30, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST In-vitro biochemical assays make the high-throughput screening of large compound libraries possible; however, without a strong hit-to-lead process, time and money are often wasted seeking out the most promising starting points. Register for this webinar to learn best practices for triaging hits and focusing efforts.
Thursday, September 30, 2021 at 1pm EDT| 12pm CDT| 10am PDT Formulating drugs to facilitate patient adherence, especially for pediatrics, is an ongoing industry challenge. Learn about challenges encountered when formulating drugs with a patient-centric focus, clinical recommendations for pediatric dosage forms, repurposing strategies for formulation development, and technology platforms to optimize oral dosage forms.
Tuesday, September 28, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST In the last few years, the issuance of the ISO 10993-18:2020 medical device guidance and several high-profile publications and round-robin studies have resulted in the FDA increasing scrutiny of E&L analyses for both drugs and devices. Join our panel of industry experts to discuss these changes and to learn the direction E&L may take into the future.
Thursday, September 16, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST Choosing the right sterilization technique for your drug product and its packaging is not always a simple decision. Join the webcast on September 15th to learn about standard sterilization processes, be introduced to newer techniques, and understand how these techniques have been applied to parenteral packaging components.
Wednesday, September 15, 2021 at 10am EDTDrug manufacturing demands and increased regulatory oversight are prompting pharmaceutical manufacturers to consider new processes for oral solid dose and aseptically processed drugs. A cross-section of industry experts will offer insight on emerging trends, technologies, and processes in this Technology Forum.
Wednesday, September 8, 2021 at 8am EDT| 5am PDT| 1pm BST| 2pm CEST AI has opened up an enormous amount of possibilities for biomedical and life sciences organizations to use growing volumes of data to accelerate and improve upon critical processes that can speed time to value and improve patient outcomes. Learn how next generation AI is revolutionizing how these organizations can deliver innovation and value to patients and overcome the constraints of legacy technology, easier and faster than ever before.
Thursday, September 2, 2021 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST
Tuesday August 31, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CESTEfficiency for validation, changes to traditional practices to be more efficient and effective .
Thursday, August 26, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST This webcast will explore the benchmark practices for rapid progression from first-in-human to large-scale commercial manufacture for microdosing API. Micro-dosing at a commercial scale made effortless.
Monday, August 23, 2021 at 2pm EDT | 1pm CDT | 11am PDT What do Plato, Roombas, and digital twins for pharma manufacturing have in common? Learn how digital twins, powered by artificial intellingence, can reproduce conditions happening in physical assets to identify and optimize manufacturing process variables, predict outcomes, and empower to bio/pharma companies take action.
Friday, August 13, 2021 at 11am EDT| 8am PDT| 4pm BST|5pm CEST
Thursday, August 5, 2021 at 11am EDT| 8am PDT| 4pm BST|5pm CEST
Thursday, July 22, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Local delivery of monoclonal antibodies to the lung is enabled by spray drying to manufacture stable, respirable dry powders. An inhaled formulation of bevacizumab was effective in vivo, reducing tumor burden in a rat model of non-small cell lung cancer.
Wednesday, July 21, 2021 This Technology Forum will explore the current state of commercialization for cell and gene therapies and the patient and physician perspective, as well as the need for technologies, processes, and strategies to ensure competent delivery of these treatments to patients.
